Health.Zone Web Search

  1. Ads

    related to: parkinson's progression markers initiative (ppmi)

Search results

  1. Results from the Health.Zone Content Network
  2. Alzheimer's Disease Neuroimaging Initiative - Wikipedia

    en.wikipedia.org/wiki/Alzheimer's_Disease...

    Alzheimer's Disease Neuroimaging Initiative. Alzheimer's Disease Neuroimaging Initiative ( ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). [1] This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well ...

  3. Parkinsonism - Wikipedia

    en.wikipedia.org/wiki/Parkinsonism

    Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia (slowed movements), rigidity, and postural instability. [1] [2] Both hypokinetic (bradykinesia and akinesia) as well as hyperkinetic (cogwheel rigidity and tremors at rest) features are displayed by Parkinsonism. [3] These are the four motor symptoms found in Parkinson's ...

  4. The Stages of Parkinson's Disease - Healthline

    www.healthline.com/health/parkinsons/stages-of...

    The progression of Parkinson’s is broken down into five distinct stages. Learn how and when patients may progress from stage to stage as well as the key symptoms associated with each.

  5. 5 Stages of Parkinson‘s Disease - Healthline

    www.healthline.com/health/parkinsons/stages

    Stage 3. Stage 3 is the middle stage in Parkinson’s, and it marks a major turning point in the progression of the disease. Many of the symptoms are the same as those in stage 2. However, you ...

  6. Parkinson’s Disease Symptoms to Recognize - Healthline

    www.healthline.com/health/parkinsons/symptoms

    Parkinson’s is a chronic and progressive disorder, meaning that symptoms grow worse over time. There’s a wide range of symptoms and symptom severity: while some people become severely disabled ...

  7. Michael J. Fox - Wikipedia

    en.wikipedia.org/wiki/Michael_J._Fox

    Since 2010, he has led a $100-million effort, which is the Foundation's landmark observational study, to discover the biological markers of Parkinson's disease with the Parkinson's Progression Markers Initiative (PPMI). Fox manages the symptoms of his Parkinson's disease with the drug carbidopa/levodopa, and he had a thalamotomy in 1998.

  1. Ads

    related to: parkinson's progression markers initiative (ppmi)